CalciMedica (CALC)

• Market cap: $25.9M
• 1 day: -7.25%
• 5 days: -8.13%
• 1 month: -23.81%
• 3 months: -31.18%
• 6 months: -53.85%
• Year to date: -41.64%
• 1 year: -57.33%
• 5 years: -99.17%
• 10 years: -99.17%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Employees: 13

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

21% more funds holding

Funds holding: 24 [Q3] → 29 (+5) [Q4]

11% more capital invested

Capital invested by funds: $13.6M [Q3] → $15.1M (+$1.54M) [Q4]

3.14% more ownership

Funds ownership: 28.49% [Q3] → 31.63% (+3.14%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $13 577% upside
• Avg. target: $14.50 655% upside
• High target: $16 733% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Joseph Pantginis 18% 1-year accuracy 76 / 411 met price target	733% upside $16	Buy Reiterated	4 Mar 2025
LUCID CAPITAL MARKETS Dev Prasad 33% 1-year accuracy 1 / 3 met price target	577% upside $13	Buy Initiated	17 Dec 2024